IOM Outlines Strategy for U.S. Global HIV/AIDS Program Assessment
July 9, 2010
An Institutes of Medicine report outlines the organization's strategic approach to the evaluation of U.S. global HIV/AIDS programs -- an assessment mandated by the reauthorization of PEPFAR in 2008. According to the report, the IOM will begin the evaluation "in 2010 and issue a report with findings and recommendations in 2012." Major elements of the evaluation include: assessing PEPFAR's contribution to changes in health impact, "assessing the implementation and effects of program components" and providing guidance to "maximize the potential for programs to have a future positive health impact" (7/7). More information on the IOM report is available on Kaiser's Policy Tracker tool (7/7).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)